technology

Medical devices business Confluent accounted for a majority of NAV in a transaction involving Ampersand Capital Partners.

The process, which was also backed by two co-investors, centres on a 2010-vintage fund with 10 assets across software, technology and healthcare sectors.

The process centred around star fintech asset Trustly and included backing from Investment Corporation of Dubai and Retirement System Investment Commission of South Carolina.

The venture capital specialist has closed a $125m fund targeting primary-, early secondary- and direct investments in technology-focused buyout funds.

The second installment in our series on disruption looks at Collective Equity Ownership, which offers an alternative to the direct secondaries market.

The secondaries firm, along with investment manager Wafra, has acquired a stake in Siris Capital Capital Group and will fund the repurchase of another minority stake sold at the firm's inception.

The firm backed a $185m secondaries process on the Gulf-headquartered investor's 2007-vintage tech fund and made a stapled commitment to its successor.

This was the 12th deal from the directs-focused's firms latest fund, which is around 50% deployed.

The Berlin-headquartered firm continues to acquire assets on a deal-by-deal basis and is unlikely to deviate from this strategy any time soon.

The deal was valued at around $450m and marks GIC's entry as an investor.